VIDEO BRIEFING: Reduce your credit card swipe fees
Missed our briefing a couple of weeks ago about APC’s new group purchasing agreement with WorldPay?
Missed our briefing a couple of weeks ago about APC’s new group purchasing agreement with WorldPay?
Plus: Letendre honored and APC represents at recent convention
It’s called geofencing — the ability to target digital messaging to individuals who meet a defined demographic criteria within a defined geographic area.
It’s the 4th quarter. Can we come from behind? It’s the start of the fourth quarter and we’re behind — and I’m not talking about a football game.
In light of recent developments, we’ve updated our official statement on shortage drug compounding and semaglutide, as well as our Prescriber Brief on peptide compounding.
Last week, a Florida District Court judge dismissed Novo Nordisk’s lawsuit against Brooksville Pharmacy, one of the four APC members the drugmaker sued back in June over semaglutide compounding in shortage.
APC has leveraged the strength of our large number of Pharmacy-Facility Members to strike a deal with Capital Drug on finished-form drugs.
FDA this week issued a statement warning of potential risks associated with compounded ketamine, including oral formulations, for treatment of psychiatric disorders.
The providers you work with may be smart cookies, but they don’t always know compounding. Providers need to know about those issues, and it’s up to you to keep them informed.
Voting is now open for seats on the 2024 APC Board of Directors.